269
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Negative association between antioxidant vitamin intake and non-alcoholic fatty liver disease in Chinese non-diabetic adults: mediation models involving superoxide dismutase

ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 670-677 | Received 01 Aug 2020, Accepted 14 Sep 2020, Published online: 28 Sep 2020

References

  • Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70(3):531–544.
  • Younossi ZM, Henry L. The impact of obesity and type 2 diabetes on chronic liver disease. Am J Gastroenterol. 2019;114(11):1714–1715.
  • Bellanti F, Villani R, Facciorusso A, et al. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. Free Radic Biol Med. 2017;111:173–185.
  • Masarone M, Rosato V, Dallio M, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018;2018:9547613.
  • Park S, Ham JO, Lee BK. Effects of total vitamin A, vitamin C, and fruit intake on risk for metabolic syndrome in Korean women and men. Nutrition. 2015;31(1):111–118.
  • Lee CH, Chan RSM, Wan HYL, et al. Dietary intake of anti-oxidant vitamins A, C, and e is inversely associated with adverse cardiovascular outcomes in Chinese-a 22-years population-based prospective study. Nutrients. 2018;10(11):1664.
  • Ivancovsky-Wajcman D, Fliss-Isakov N, Salomone F, et al. Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease. Dig Liver Dis. 2019;51(12):1698–1705.
  • Xu R, Tao A, Zhang S, et al. Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis. Int J Clin Exp Med. 2015;8(3):3924–3934.
  • Hasegawa T, Yoneda M, Nakamura K, et al. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther. 2001;15(10):1667–1672.
  • Nobili V, Manco M, Devito R, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008;48(1):119–128.
  • Han JM, Jo AN, Lee SM, et al. Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2014;29(6):1265–1272.
  • Da Silva HE, Arendt BM, Noureldin SA, et al. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr Diet. 2014;114(8):1181–1194.
  • Zhong G, Kirkwood J, Won KJ, et al. Characterization of Vitamin A metabolome in human livers with and without nonalcoholic fatty liver disease. J Pharmacol Exp Ther. 2019;370(1):92–103.
  • Yu J, Liu H, He S, et al. Sex-specific negative association between iron intake and cellular aging markers: mediation models involving TNFα. Oxid Med Cell Longev. 2019;2019:4935237
  • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
  • Fan JG, Jia JD, Li YM, Chinese Association for the Study of Liver Disease, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis. 2011;12(1):38–44.
  • Hayes AF. Partial, conditional, and moderated moderated mediation: quantification, inference, and interpretation. Commun Monographs. 2018;85(1):4–40.
  • Goon JA, Nor Azman NHE, Abdul Ghani SM, et al. Comparing palm oil tocotrienol rich fraction with α-tocopherol supplementation on oxidative stress in healthy older adults. Clin Nutr Espen. 2017;21:1–12.
  • Miyazaki H, Takitani K, Koh M, et al. The α-tocopherol status and expression of α-tocopherol-related proteins in methionine-choline deficient rats treated with vitamin E. J Clin Biochem Nutr. 2014;54(3):190–197.
  • Mustacich DJ, Leonard SW, Devereaux MW, et al. Alpha-tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats. Free Radic Biol Med. 2006;41(7):1069–1078.
  • Singh N, Chander Narula S, Kumar Sharma R, et al. Vitamin E supplementation, superoxide dismutase status, and outcome of scaling and root planing in patients with chronic periodontitis: a randomized clinical trial. J Periodontol. 2014;85(2):242–249.
  • Bartolini D, Torquato P, Barola C, et al. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E). J Nutr Biochem. 2017;47:120–131.
  • Ipsen DH, Rolin B, Rakipovski G, et al. Liraglutide decreases hepatic inflammation and injury in advanced lean non-alcoholic steatohepatitis. Basic Clin Pharmacol Toxicol. 2018;123(6):704–713.
  • Chung MY, Yeung SF, Park HJ, et al. Dietary alpha- and gamma-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. J Nutr Biochem. 2010;21(12):1200–1206.
  • Uchida T, Nomura S, Oda H, et al. γ-Tocopherol is metabolized faster than α-tocopherol in young Japanese women. J Nutr Sci Vitaminol. 2018;64(6):399–403.
  • Niki E, Traber MG. A history of vitamin E. Ann Nutr Metab. 2012;61(3):207–212.
  • Saeed A, Dullaart RPF, Schreuder T, et al. Disturbed vitamin a metabolism in non-alcoholic fatty liver disease (NAFLD). Nutrients. 2017;10(1):29.
  • Arya A, Azarmehr N, Mansourian M, et al. Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies. Arch Physiol Biochem. 2019:1–8.DOI:10.1080/13813455.2019.1659827.
  • Patlar S, Baltaci AK, Mogulkoc R. Effect of vitamin A administration on free radicals and lactate levels in individuals exercised to exhaustion. Pak J Pharm Sci. 2016;29(5):1531–1534.
  • Madan K, Bhardwaj P, Thareja S, et al. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006;40(10):930–935.
  • Wei J, Lei GH, Fu L, et al. Association between dietary vitamin c intake and non-alcoholic fatty liver disease: a cross-sectional study among middle-aged and older adults. PLoS One. 2016;11(1):e0147985
  • Zhou MC, Zhu L, Cui X, et al. Reduced peripheral blood mtDNA content is associated with impaired glucose-stimulated islet β cell function in a Chinese population with different degrees of glucose tolerance. Diabetes Metab Res Rev. 2016;32(7):768–774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.